CRF NEWS

Primera edición de temas seleccionados sobre Cardiología Intervencionista. Un proyecto en colaboración con la Revista Colombiana de Cardiología (RCC) y el Skirball Center for Innovation (CRF) aplicada en la ciudad de New York.



ADVANCED APPLICATIONS OF TEE IMAGING FOR TRANSCATHETER MITRAL AND TRICUSPID PROCEDURES

G. Burkhard Mackensen, MD, PhD, FASE



STATE OF THE ART MANAGEMENT STRATEGIES IN ACS: NON-STEMI AND STEMI

Nicholas J. Lembo, MD, FACC, FSCAI



Perspectives on structural heart revolution. (CRF & RCC)

Perspectives on structural heart revolution. (CRF & RCC)

Lo invitamos a ver la conferencia del Dr. Susheel Kodali, MD. Acerca de la enfermedad estructural y su tratamiento intervencionista.



Subgroup Analysis from the RE-DUAL PCI Trial Dual Antithrombotic Therapy with Dabigatran in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

Subgroup Analysis from the RE-DUAL PCI Trial Dual Antithrombotic Therapy with Dabigatran in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

Acceda a la presentación de los doctores Jonas Oldgren, Philippe Gabriel Steg, Stefan H. Hohnloser, Gregory Y. H. Lip, Stephen G. Ellis, Takeshi Kimura, Matias Nordaby, Eva Kleine, Jurriën M. ten Berg, Deepak L. Bhatt, Christopher P. Cannon.



LDL Cholesterol Lowering with Evolocumab and Outcomes in Patients with Peripheral Artery Disease: Insights from the FOURIER Trial.

LDL Cholesterol Lowering with Evolocumab and Outcomes in Patients with Peripheral Artery Disease: Insights from the FOURIER Trial.

Acceda a la presentación de los doctores Marc P. Bonaca, Patrice Nault, Robert P. Giugliano, Anthony C. Keech, Armando Lira Pineda, Estella Kanevsky, Julia Kuder, Sabina A. Murphy, J. Wouter Jukema, Basil S. Lewis, Lale Tokgozoglu, Ransi Somarathe, Peter S. Sever, Terje R. Pedersen, Marc S. Sabatine



PREVAIL: 5-Year Outcomes From a Randomized Trial of Left Atrial Appendage Closure vs Medical Therapy in Patients With Nonvalvular Atrial Fibrillation

PREVAIL: 5-Year Outcomes From a Randomized Trial of Left Atrial Appendage Closure vs Medical Therapy in Patients With Nonvalvular Atrial Fibrillation

Acceda a la presentación del Dr Saibal Kar, MD TCT 2017 Late Breaking Clinical Trial Denver, CO USA



Time at blood pressure target and the risk of cardiovascular diseases and mortality. (CRF & RCC)

Time at blood pressure target and the risk of cardiovascular diseases and mortality. (CRF & RCC)

Acceda a la presentación del Dr. Mar Pujades-Rodriguez, MBBS, PhD



3 Year Clinical Outcome and Cost-Effectiveness of FFRGuided PCI in Stable Patients with Coronary Artery Disease: FAME 2 Trial

3 Year Clinical Outcome and Cost-Effectiveness of FFRGuided PCI in Stable Patients with Coronary Artery Disease: FAME 2 Trial

Acceda a la presentación de los doctores William F. Fearon, MD, Takeshi Nishi, MD, Bernard De Bruyne, MD, PhD, Derek B. Boothroyd, PhD; Emanuele Barbato, MD, PhD, Pim Tonino, MD, PhD, Peter Jüni, MD, Nico H.J. Pijls, MD, PhD, and Mark A. Hlatky, MD



Oral Anticoagulation and Triple Therapy in Acute Coronary Syndromes

Oral Anticoagulation and Triple Therapy in Acute Coronary Syndromes

Lo invitamos a ver la conferencia del Dr. George Dangas, MD, PhD., sobre Oral Anticoagulation and Triple Therapy in Acute Coronary Syndromes



Pulmonary Embolism: what modern day interventionalists need to know.(CRF & RCC)

Pulmonary Embolism: what modern day interventionalists need to know. (CRF & RCC)

Lo invitamos a ver la conferencia del Dr. Sahil A. Parikh, sobre Pulmonary Embolism: what modern day interventionalists need to know (CRF & RCC). Dr. Sahil A. Parikh, MD, FACC, FSCAI.



Bioskills Session: Focus on Structural Heart Anatomy (CRF & RCC)

Bioskills Session: Focus on Structural Heart Anatomy (CRF & RCC)

Lo invitamos a ver la conferencia del Dr. Mark Reisman sobre el tema Focus on structural heart anatomy.